I don't get it. GB just announced excellent past quarter results on Jan. 28. So what happens? The price plunges instead of climbing. It doesn't compute. GB have made good strategic aquisitions accretive of the bottom line and supportive of their domination of the market and efficiency in production of implantable power sources, etc. Their accounting had always seemed open and above board. More devices (for the heart, brain) using their batteries and capacitors (see news from Medtronic, St. Jude, and Guidant)have recently been approved.